As more research unfolds, their role in functional medicine will likely continue to expand, offering new hope for those suffering from chronic conditions driven by metabolic and immune dysfunction.
Data on duration of medication use, adherence, discontinuation and concomitant medications cannot be captured from prescriptions databases, and dosing data for liraglutide and dulaglutide were unavailable or incomplete, so it was not possible to determine whether patients were optimized on their baseline GLP-1 RA
Explaining the list price of Saxenda (liraglutide)
From a mechanistic standpoint, both compounds activate the same GLP-1 and GIP receptors, which means concurrent administration would likely result in receptor saturation at those pathways without proportional additive benefit
In: McManusLMMitchellRN, editors